Eli Lilly’s Alzheimer’s drug wins FDA approval

Date:

July 2, 2024

An Eli Lilly & Co. Alzheimer’s drug won Food and Drug Administration approval Tuesday, capping the medication’s bumpy ride through the U.S. regulatory process and adding a second new treatment option for patients in earlier stages of the disease.

Source link

AI is learning from what you said on Reddit, Stack Overflow or Facebook. Are you OK with that?

Alabama football lands 4-star tight end Kaleb Edwards: What it means for Tide

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Eli Lilly’s Alzheimer’s drug wins FDA approval

Recent posts

E-Trade reportedly weighs banning meme-stock icon Roaring Kitty, despite worries of a backlash

Shell expects ‘significantly lower’ gas trading results in Q1 following bumper performance in Q4

Freshpet’s stock jumps toward a multiyear high after an unexpected quarterly profit

ECB ready to start cutting interest rates, chief economist says

Crude oil reverses most of April gains as traders shrug off Middle East tensions

Blink Charging’s CEO says drop in EV sales is mostly a Tesla problem

Zillow forecasts slower second quarter, amid caution among first-time buyers and agents

Trump Media shares continue to drop, as SEC move threatens to ding shareholders

The soft economic data has been bad. The hard data is starting to weaken as well.

5 stock-market takeaways as Biden sees ‘incredible pressure’ to step aside after debate

The feds are scrutinizing credit-card rewards. That could help frequent fliers get more out of their miles.

Coach, Kate Spade parent reports revenue miss amid weakness in North America

Toyota unveils safety projects in wake of vehicle-testing violations

Amazon hit with $5.9 million fine as California says it failed to disclose quotas to workers

Shell launches $3.5 billion buyback after earning $7.7 billion

Related articles

Arkhouse, Brigade reportedly try to sweeten offer to buy Macy’s

Gold prices look to settle at 1-month high as silver jumps nearly 4%

JPMorgan’s top strategist Marko Kolanovic is leaving after missing stocks’ historic rally

Hurricane Beryl puts focus on oil with climate change likely to intensify storms

Biden offers latest debate excuse as Harris pulls level in one betting market

Oil prices extend gains on July 4 travel expectations, Hurricane Beryl worries

Consumer stocks made a comeback in June — but U.S. households are still feeling the pinch

Bond market participants brace for bigger deficits under either Trump or Biden

Company

Follow us